$ 18.43
Key Takeaways
Risk factor
Negligible price volatility
Profitability factor
Somewhat favourable analyst view
About
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment...
Company Valuation
Based on key historical and expected multiples, the stock is slightly overvalued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBI
Target Price
The average target price of KVUE is 21 and suggests 16% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
